Domrex Pharma obtains the ISO 13485:2016 certification for its quality management system

LAVAL, QC, July 29, 2019 /CNW/ - Domrex Pharma, a Canadian leader in the medical devices industry, announces its obtention of the ISO 13485:2016 certification delivered by Intertek.

Domrex Pharma is proud to announce that it has obtained the ISO 13485:2016 certification. This certification testifies the commitment of the Canadian company towards its quality processes. Issued by Intertek, this certification covers the quality management system for all Domrex Pharma's activities.

The Standard's Spectrum of Application
Although this standard applies to medical devices, the requirements apply equally to associated services as supplied by the organization. The specific requirements are expressed through the distribution of high-quality and innovative (if applicable) products, as well as customer satisfaction.

Appointment of A Quality Director
In order to reach Domrex Pharma's quality goals, the Direction has appointed Mr. Gabriel Ferland as Director of Quality to ensure the diffusion of the commitment to the workforce, the clients and the suppliers (if applicable). ''With his rigorous work as the Director of Business Development, Gabriel was the ideal candidate for this position'', mentions Mr. Dominique Ferland, CEO.

A Fulfilled Promise
For over a decade, Domrex Pharma specializes in the distribution of safety medical devices and diabetes products. The issue of the certification strengthens the quality promise present in all the company's managerial areas. Therefore, Domrex Pharma commits to respect all those rigorous processes in order to honour the actual and future customers and partners satisfaction.

SOURCE Domrex Pharma Inc.